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Abstract
OBJECTIVE: Allergic rhinitis (AR) is a common
health problem. Summer acupoint application
treatment (SAAT) is reported to effectively treat
and prevent AR from seasonal onset. In the present
study, we aimed to evaluate its effects, especially
on the course of AR, through a retrospective study.
METHOD: A cross-sectional multicenter study was
performed based on patients treated between
2008 and 2009 in 13 clinical centers in China. A to-
tal of 1058 outpatients aged ≥2 years with docu-
mented AR and ≥1 year SAAT were eligible for en-
rollment. A case report form (CRF) was completed
by both patient and doctor. The CRF was designed
to collect data on the patient's history of SAAT, AR
condition, and self-reported health condition. The
outcomes (dependent variables) were incidence
and intensity of AR and concomitant medications
used. Data were analyzed with ordinal logistic re-
gression (OLR).
RESULTS: Treatment course and seasonal pattern
of AR were related to all dependent variables posi-
tively. After controlling for sample bias and con-
founding factors, the findings suggested that a
3-year treatment course had better efficacy (OR/ in-
cidence of AR: 2.57, 95%CI: 1.76-3.76; OR/intensity
of AR: 2.17, 95%CI: 1.50-3.17; OR/ concomitant med-
ications: 2.20, 95% CI: 1.50-3.23) compared with a
2-year or less treatment course.
CONCLUSION: The results showed that: 1)the
length of treatment course was positively associat-
ed with the efficacy of SAAT (the longer the treat-
ment course, the better the efficacy); and 2)SAAT
was more efficacious in treating seasonal AR than
non-seasonal AR.
© 2012 JTCM. All rights reserved.
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INTRODUCTION
Allergic rhinitis (AR) is a global health problem, with a
prevalence between 10% and 20%.1 To avoid this dis-
ease, patients usually have to stay away from their aller-
gens, causing disruption to normal living. Under the
guidance of the theory of Chinese Medicine (CM),
Summer acupoint application treatment (SAAT), a
treatment administered in the summer time with a
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type of herbal moxibustion, has been reported to effec-
tively prevent AR from onset.2-4
According to CM theory, AR, a consequence of disor-
ders in the respiratory system, is related to lung defi-
ciencies. Patients with AR are often sensitive to cold
and have a lack of yang Qi inside their body. With
herbal moxibustion, SAAT can improve the yang Qi of
AR patients. Technically, one feature of SAAT is that
the treatment must be administered during the three
hottest days in the summer.2 Due to the non-invasive
and low-cost nature of SAAT, this method has been in-
creasingly used in CM clinics in China. However, there
still exists some debate about key factors of this meth-
od, such as the optimal treatment course, the timing of
administering it, and the proper herbal composition.
Most conclusions made before were based on clinical
studies conducted in a short period (less than 1 year)2,5-8
and/or with small sample size.9,10 Therefore, the efficacy
of a full treatment course of SAAT has not yet been
clearly addressed.
Motivated by this aim, a retrospective study was per-
formed to investigate the efficacy in relation to treat-
ment course. In addition, the features (duration, onset
season, onset incidence) of AR were researched as well.
The results were expected to optimize the use of SAAT
for AR.
METHODS
Study population
This was a cross-sectional multicenter study based on
patients from 13 clinical centers in China. Outpatients
aged ≥2 years with documented AR and treatment
with SAAT for 1 year or more, were eligible for enrol-
ment. The diagnostic standard for AR that we used
was the Principles of Diagnosis and Recommended
Treatment of Allergic Rhinitis.11
All patients recruited were treated in the summers of
2008 and 2009. Those who were excluded: 1) were
pregnant or lactating; 2) were allergic to the herb or ex-
cipient; 3) had a body temperature of 37.5°C or above;
4) produced yellow and thick sputum; 5) presented
with uncontrolled diabetes; and 6) were previously di-
agnosed with bronchiectasis, endobronchial tuberculo-
sis, pulmonary fibrosis, severe heart, liver or kidney dis-
ease, mental disease or cancer. Written informed con-
sent was signed by each patient or his guardian.
The protocol was approved by the Ethics Committees
of the Institution of Basic Research in Clinical Medi-
cine, CACMS (China Academy of Chinese Medi-
cine).12 This study was also registered in the Chinese
Clinical Trial Registry with the registration No. of
ChiCTR-TNRC-10001292.
Data collection
Patients were interviewed at the screening center by
doctors trained for the purpose using a questionnaire
divided into 2 parts. In the first part, patients reported:
age, sex, main symptoms to be treated (cough, sputum,
wheezing, shortness of breath, asthma, nasal conges-
tion, sneezing), duration of AR (years), seasonal pat-
tern of AR (seasonal, non-seasonal), incidence of AR
before SAAT treatment("1"=less than once per month,
"2"=2-3 times per month, "3" = 1-2 times per week,
"4"=more than 3 times per week), intensity of AR
(from "0" = least severe level to "10" = most severe
level), and duration of treatment course (years). For pa-
tients under 12 years' old, the questions were answered
by their guardians. In the second part, doctors reported
the information of diagnosis and intensity of AR (3 lev-
els, "1"=l ight, "2"=moderate, "3"=heavy), according to
the Principles of Diagnosis and Recommended Treat-
ment of Allergic Rhinitis.11
Outcomes measured
Outcomes (dependent variables) included incidence
and intensity of AR, and concomitant medications. In-
cidence and intensity of AR were defined as the num-
ber of times and the level of severity of AR occurring
in the previous year for each patient, respectively. Con-
comitant medication included the types of medications
and their course of administration during AR episodes
and/or remission.
These outcomes were evaluated by the patients them-
selves or their guardians, with the level of symptoms be-
ing compared to the baseline before SAAT treatment.
The efficacy (outcomes) was rated in five categories: "
1"=much worse than before, "2"=mildly worse, "3"=no
change, neither better nor worse, "4"=mildly effective
and "5"=very effective.
Data analysis
The original data were double-entry, inspected and
stored as e-documents in the "Clinical Data Collection
& Management Database", which was developed by
CACMS.
The association between eight individual factors and
three outcomes was evaluated with ordinal logistic re-
gression (OLR).13 The statistical software R Version
2.12.1 and package "epicalc" were used.
Eight factors were: age (groups of >65 years old and ≤
65 year old), sex, duration of AR (groups of >10 years
and ≤10 years), seasonal pattern of AR (non-seasonal,
seasonal), treatment course (groups of 1, 2, and ≥3 years
duration), incidence of AR before SAAT treatment, in-
tensity of AR reported by patients, and intensity of AR
reported by doctors. Three outcomes are: incidence of
AR, intensity of AR, concomitant medications.
RESULTS
A total of 1058 patients (41.63% male and 58.37% fe-
male) were enrolled in this research. The mean age was
34.97 (SD=20.45) years, the mean duration of AR was
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8.75 (SD=8.45) years, the mean treatment course of
SAAT was 1.82 (SD=1.71) years. The most prevalent
allergic symptoms were sneezing (81.10% ) and nasal
congestion (79.10% ). Of all the cases, seasonal onset
accounted for 62.9% , of which 68.54% occurred in
winter.
The results showed that the incidence and the intensity
of AR and the concomitant medications decreased
with the duration of the treatment course. Taking the
incidence of AR as an example, the percentages of "ef-
fective" ("very effective" plus "mildly effective") for
1-year, 2-year, and ≥3-year durations of treatment were
69.5%, 75.4% and 79 %, respectively, compared with
those of "no change" (30% , 24.8% and 21% ) and
those of "worse" (0.5%, 0% and 0%). This suggested
that SAAT was a potential method to prevent AR from
onset. Interestingly, the percentages of "very effective"
with ≥3-year duration of treatment were all significant-
ly higher than those with 1-year or 2-year durations of
treatment (P<0.001) for all the three outcomes. This
indicated the importance of treatment course for the ef-
ficacy of SAAT on AR, which was also observed by Wu
et al.14
OLR analysis showed that duration of treatment
course had a positive association with incidence (OR:
1.21; 95%CI: 1.12-1.33), intensity (OR: 1.19; 95%CI:
1.10-1.30), and concomitant medication (OR: 1.18;
95%CI: 1.09-1.29), as depicted in Table 2. The same
trend could be found for the seasonal pattern of AR
(incidence OR: 1.66; 95%CI: 1.29-2.14; intensity OR:
1.75; 95% CI: 1.36-2.26; concomitant medication
OR: 1.59; 95%CI: 1.23-2.05). On the other hand, the
incidence of AR before SAAT treatment showed a nega-
tive association with incidence (OR: 0.82; 95% CI:
0.73-0.92), intensity (OR: 0.81; 95% CI: 0.73-0.91),
and concomitant medication (OR: 0.82; 95% CI:
0.73-0.92) in the present year. The other five factors
(gender, duration of disease, intensity of AR-Doctors,
and intensity of AR-Patients) showed no significant ef-
fect on the outcomes (Table 2).
Table 1 Distribution of the outcomes in three levels of treatment course
Treatment course
Incidence of AR (missing=9)
Intensity of AR onset (missing=11)
Concomitant medications (missing=41)
1 y
2 y
≥3 y
1 y
2 y
≥3 y
1 y
2 y
≥3 y
Very effective
(%)
122(20.8)
67(23.4)
72(40.9)
134(22.9)
64(22.5)
64(36.4)
88(15.4)
48(17.3)
55(32.5)
Mildly effective
(%)
286(48.7)
148(51.7)
67(38.1)
264(45.1)
150(52.6)
77(43.8)
232(40.7)
114(41)
60(35.5)
No change (%)
176(30)
71(24.8)
37(21)
183(31.2)
70(24.6)
35(19.9)
249(43.7)
116(41.7)
52(30.8)
Worsea(%)
3(0.5)
0(0)
0(0)
5(0.9)
1(0.4)
0(0)
1(0.2)
0(0)
2(1.2)
Total
(%)
587(100)
286(100)
176(100)
586(100)
285(100)
176(100)
570(100)
278(100)
169(100)
P value
0.24
<0.001a
0.07
<0.001a
0.76
<0.001a
Notes: aSince no case fell in the category of "much worse than before", it was combined with the category of "mildly worse" to form a new
category named "worse".
Table 2 The association between all factors and outcomes by OLR analysis, adjustedOR (95%CI)
Treatment coursea
Gender(female vs male)
Age (>65 vs ≤65)
Duration of disease (>10 vs ≤10)
Intensity of AR-D (reported by doctor)
Intensity of AR-P (reported by patient)
Incidence of AR before SAATa
Seasonal pattern of ARa
Incidence of AR
1.21(1.12,1.33)
1.11(0.87,1.42)
1.00(1.00,1.01)
0.99(0.97,1.01)
0.97(0.75,1.26)
0.93(0.85,1.01)
0.82(0.73,0.92)
1.66(1.29,2.14)
Intensity of AR
1.19(1.10,1.30)
1.03(0.80,1.31)
1.01(1.00,1.01)
0.99(0.98,1.01)
1.02(0.78,1.32)
0.90(0.82,0.98)
0.81(0.73,0.91)
1.75(1.36,2.26)
Concomitant medications
1.18(1.09,1.29)
0.90(0.70,1.15)
1.00(1.00,1.01)
1.00(0.99,1.02)
1.28(0.99,1.68)
0.91(0.83,1.00)
0.82(0.73,0.92)
1.59(1.23,2.05)
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To avoid the bias of sample selection, the adult sample
aged 18-83 were retained to mine the effect of treat-
ment course. In addition, we put "age" and "duration"
in the OLR model along with our key factor – dura-
tion of treatment course - to eliminate the potential
confounding effects. The result again suggested that
the longer treatment course, the better the efficacy. As
shown in Table 3, the odds ratios of incidence, intensi-
ty, and concomitant medications for patients with ≥
3-year treatment durations vs. patients with 1-year
treatment durations were 2.75, 2.17 and 2.20, respec-
tively. However, the odds ratios for patients with 2-year
treatment durations vs. patients with 1-year treatment
durations were around 1, which meant no significant
difference between the efficacy of 1-year treatment du-
rations and that of 2-year treatment durations (Table 3).
Table 3 The association between treatment course and out-
comes in adult group (aged 18-83), adjustedOR (95%CI)
Treatment course ref.=1 y
=2 y
≥3 y
Incidence of AR
1.20(0.88,1.64)
2.57(1.76,3.76)a
Intensity of AR
1.13(0.83,1.55)
2.17(1.50,3.17)a
Concomitant
medications
0.99(0.72,1.34)
2.20(1.50,3.23)a
Notes: aadjustedOR: adjusted by age and duration.
DISCUSSION
The efficacy of SAAT on AR has been confirmed exten-
sively,10,15,16 but the effect of treatment course duration
is still under debate. Xia8 recommended that the prop-
er treatment course be one year, whereas Xu10 and
Chen15 suggested a 3-year course. Clinical reports have
shown that 1-year and 3-year treatment durations had
no significant difference on AR, i.e., the effectiveness
rate with a 1-year course was 69%-96.9% ,8,15,17 while
that of a 3-year course was 71.4%-96.7% .10,16 Mean-
while, a few studies have indicated the tendency to in-
creased effectiveness with longer treatment course.16,18
We obtained a similar conclusion as well. Nevertheless,
we found that the efficacy of a 3-year treatment dura-
tion was better than that of either a 1-year or 2-year
treatment duration.
A seasonal pattern of SAAT had been clearly depicted
in previous analyses, which is a result of the principle
of SAAT. According to CM, insufficient Lung-Qi in
the human body facilitates AR seasonal onset.19 Herbal
moxibustion, especially SAAT, can warm and strength-
en the Lung-Qi. First, the basic herbal composition
can expel cold and promote circulation of Qi. Second,
with the help of this herbal composition, this treat-
ment can stimulate the special acupuncture points be-
longing to Back-shu, e.g., Fengmen (UB 12) and Fei-
shu (BL 13), and motivate dorsal root ganglia and spi-
nal nerves. This may help to regulate the synthesis and
release of neurotransmitters.20 Third, this treatment is
performed during the three hottest days in summer,
when yang qi is believed to be at the highest level. This
can enhance the herbal effect as it penetrates the acu-
points.
This study attempted to assess the efficacy of SAAT in
regard to AR incidence, intensity and concomitant
medications used. The results of OLR analysis showed
that the treatment course duration was positively associ-
ated with the efficacy of SAAT: the longer the treat-
ment course, the better the efficacy. In addition, it was
found that SAAT was more efficacious for treating sea-
sonal AR compared with non-seasonal AR.
The measurement of disease symptoms and the out-
comes in this study deserve attention. All measured
variables in this study were self-rated. Even the intensi-
ty of AR reported by the doctor was based on subjec-
tive judgment rather than objective measures. There-
fore, future studies on the optimal treatment course
conducted with high quality design are needed.
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